middle.news

IDT Surges 30% in Quarterly Revenue, Backed by $62M in Proposals

6:05am on Monday 2nd of June, 2025 AEST Pharmaceuticals
Read Story

IDT Surges 30% in Quarterly Revenue, Backed by $62M in Proposals

6:05am on Monday 2nd of June, 2025 AEST
Key Points
  • 30% increase in unaudited quarterly revenue to $4.1 million
  • Secured $4.5 million in new contracts during Q3FY25
  • Robust pipeline with $62 million in open proposals
  • API manufacturing vertical revenue up 72%, driving growth
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Idt Australia (ASX:IDT)
OPEN ARTICLE